首頁 › 瀰漫性大B細胞淋巴瘤 › 華盛頓州 › Seattle
Seattle, WA 的 瀰漫性大B細胞淋巴瘤 臨床試驗
12 項針對 瀰漫性大B細胞淋巴瘤 的研究正在 Seattle（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- Swedish Cancer Institute (SCI), Seattle
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
招募中1 期
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
招募中2 期
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
招募中2 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
招募中2 期歡迎健康志工
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
招募中2 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
招募中2 期
- Swedish Medical Center-First Hill, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
招募中1 期
- Swedish Cancer Institute, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
其他城市的 瀰漫性大B細胞淋巴瘤 試驗
- New York City, NY21 項研究
- Baldwin Park, CA19 項研究
- Chicago, IL18 項研究
- Los Angeles, CA17 項研究
- Houston, TX17 項研究
- Boston, MA16 項研究
- Milwaukee, WI16 項研究
- Portland, OR15 項研究
- Philadelphia, PA15 項研究
- Durham, NC14 項研究
- Nashville, TN14 項研究
- Dallas, TX13 項研究
Seattle 的其他研究
- 非小細胞肺癌53 項研究
- 癌症（所有類型）50 項研究
- 前列腺癌44 項研究
- 急性髓系白血病40 項研究
- 乳癌40 項研究
- 轉移性癌症39 項研究
- 大腸直腸癌34 項研究
- 肺癌33 項研究
- 卵巢癌31 項研究
- 胰臟癌22 項研究
- 多發性骨髓瘤22 項研究
- 急性淋巴母細胞性白血病21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月1日。各研究自行設定資格標準；由研究團隊決定參與者資格。